News
The Healing Ability of Music
Tom Bajoras, a West Coast musician is taking advantage of gaps in his schedule to compose music to support his and your journey with NETs.
New Members Board of Directors
NETRF welcomes two leaders to its Board of Directors. Julie Mebane, Partner, Duane Morris, LLP, and Laurie Rains, Senior Vice President, U.S. Retail Services, Convenience and Liquor Channels, Neilsen. Learn how these new Board members hope to help those living with NETs. (MORE)
Virtual Concert for NET Research
Tiffanny and Josh Thomson hosted “Music to Ignite NET Research,” a virtual fundraiser for NETRF in honor of Dr. Aaron Vinik.
Sweat for NETRF
A group gathers for an overdrive exercise class to raise money in memory of an inspirational business leader, eGlobalTech founder and CEO Sonya Jain.
Milestone Achievements Announced in NET Cell Line Development
NETRF reports progress in the development of neuroendocrine tumor cell lines to help eliminate a decades-old obstacle in laboratory research. To stimulate progress in NET cell lines, NETRF established a Cell Line Prize, funded cell line research, and launched a collaboration with a nationally known research institute. Each of these initiatives has succeeded in establishing NET cell lines.
NETRF Welcomes New Members to its Board of Scientific Advisors
NETRF welcomes five new members to its Board of Scientific Advisors, a volunteer council of highly distinguished medical and research leaders who share NETRF’s commitment to advancing the diagnosis and treatment of neuroendocrine cancer.
It’s Our 15th Anniversary
In March of 2005, the Caring for Carcinoid Foundation was recognized as a non-profit, 501(c)3 foundation, established by a visionary group led by patient Nancy
Thank you for supporting NET research in 2019
Thank you for supporting NET research in 2019 Together we can fund research needed to find a cure for neuroendocrine cancer The 2019 results are
NETRF Awards $3.5 Million in Grants
Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF) today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12
Exploring new ground with a clinical trial of a NET cancer vaccine
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.